Literature DB >> 33967236

Alternatives to the Cerebrospinal Fluid Venereal Disease Research Laboratory Test for Neurosyphilis Diagnosis.

Christina M Marra1.   

Abstract

BACKGROUND: The diagnosis of neurosyphilis relies in large part on the cerebrospinal fluid (CSF) Venereal Disease Research Laboratory (VDRL) test, which is diagnostically specific but not sensitive.
METHODS: We determined the sensitivity and specificity of 3 CSF tests in addition to the CSF-VDRL in participants with syphilis enrolled in a research study: detection of Treponema pallidum ribosomal RNA, T. pallidum particle agglutination titer, and chemokine (C-X-C motif) ligand 13 (CXCL13) concentration. Neurosyphilis was defined as asymptomatic or symptomatic meningitis: CSF white blood cells >10/μL without or with neurological symptoms, including new vision or hearing loss.
RESULTS: Cerebrospinal fluid-VDRL, CSF T. pallidum ribosomal RNA detection, and CSF T. pallidum particle agglutination titer ≥1:640 were specific (89%-96%) but not sensitive (12%-48%). In contrast, diagnostic sensitivity of CSF-CXCL13 thresholds established from receiver operating characteristic curves using the Youden index was 78% to 83% and specificity was 76% to 81%. In individuals with nonreactive CSF-VDRL, neurosyphilis diagnosis could be confirmed by CSF-CXCL13 concentration in 69% to 75%.
CONCLUSIONS: Further studies of CSF-CXCL13 should include CSF samples from multiple cohorts and countries and should use standard neurosyphilis definitions to establish uniform thresholds for diagnosis.
Copyright © 2021 American Sexually Transmitted Diseases Association. All rights reserved.

Entities:  

Mesh:

Year:  2021        PMID: 33967236      PMCID: PMC8514150          DOI: 10.1097/OLQ.0000000000001450

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   3.868


  13 in total

1.  Sexually transmitted diseases treatment guidelines, 2015.

Authors:  Kimberly A Workowski; Gail A Bolan
Journal:  MMWR Recomm Rep       Date:  2015-06-05

2.  Has CXCL13 an added value in diagnosis of neurosyphilis?

Authors:  Khutso M Mothapo; Marcel M Verbeek; Lieven B van der Velden; C Wim Ang; Peter P Koopmans; Andre van der Ven; Foekje Stelma
Journal:  J Clin Microbiol       Date:  2015-03-18       Impact factor: 5.948

3.  CXCL13 as a cerebrospinal fluid marker for neurosyphilis in HIV-infected patients with syphilis.

Authors:  Christina M Marra; Lauren C Tantalo; Sharon K Sahi; Clare L Maxwell; Sheila A Lukehart
Journal:  Sex Transm Dis       Date:  2010-05       Impact factor: 2.830

4.  Cerebrospinal Fluid Treponema pallidum Particle Agglutination Assay for Neurosyphilis Diagnosis.

Authors:  Christina M Marra; Clare L Maxwell; Shelia B Dunaway; Sharon K Sahi; Lauren C Tantalo
Journal:  J Clin Microbiol       Date:  2017-04-05       Impact factor: 5.948

5.  Value of CXCL13 in diagnosing asymptomatic neurosyphilis in HIV-infected patients.

Authors:  RongXin Hu; Chun Lu; Sihan Lu; Yunxin Hu; Han Ma; Wei Lai; Guoxing Zhu; Peiying Feng; Rongbiao Lu; Ying Li
Journal:  Int J STD AIDS       Date:  2015-03-12       Impact factor: 1.359

6.  Cerebrospinal fluid abnormalities in patients with syphilis: association with clinical and laboratory features.

Authors:  Christina M Marra; Clare L Maxwell; Stacy L Smith; Sheila A Lukehart; Anne M Rompalo; Molly Eaton; Bradley P Stoner; Michael Augenbraun; David E Barker; James J Corbett; Mark Zajackowski; Charles Raines; Judith Nerad; Romina Kee; Scott H Barnett
Journal:  J Infect Dis       Date:  2004-01-27       Impact factor: 5.226

7.  How Well Do Neurologic Symptoms Identify Individuals With Neurosyphilis?

Authors:  Arielle P Davis; Joshua Stern; Lauren Tantalo; Sharon Sahi; Sarah Holte; Shelia Dunaway; Christina M Marra
Journal:  Clin Infect Dis       Date:  2018-01-18       Impact factor: 9.079

8.  CXCL13 chemokine as a promising biomarker to diagnose neurosyphilis in HIV-negative patients.

Authors:  Yan-Li Zeng; Yi-Qiang Lin; Ning-Ning Zhang; Chao-Ning Zou; Hui-Lin Zhang; Feng Peng; Zhao-Ji Liu; Wei-Hong Zheng; Jiang-Hua Yan; Li-Li Liu
Journal:  Springerplus       Date:  2016-06-16

9.  CXCL13, CXCL10 and CXCL8 as Potential Biomarkers for the Diagnosis of Neurosyphilis Patients.

Authors:  Cuini Wang; Kaiqi Wu; Qian Yu; Sufang Zhang; Zixiao Gao; Yudan Liu; Liyan Ni; Yuanyuan Cheng; Zhifang Guan; Mei Shi; Haikong Lu; Yongliang Lou; Pingyu Zhou
Journal:  Sci Rep       Date:  2016-09-21       Impact factor: 4.379

10.  CXCL13 and TH1/Th2 cytokines in the serum and cerebrospinal fluid of neurosyphilis patients.

Authors:  Yongxing Yan; Jun Wang; Bin Qu; Yan Zhang; Yingnan Wei; Huili Liu; Chunli Wu
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.817

View more
  2 in total

1.  Intrathecal Synthesis Index of Specific Anti-Treponema IgG: a New Tool for the Diagnosis of Neurosyphilis.

Authors:  Chloé Alberto; Christine Deffert; Nathalie Lambeng; Gautier Breville; Angèle Gayet-Ageron; Patrice Lalive; Laurence Toutous Trellu; Lionel Fontao
Journal:  Microbiol Spectr       Date:  2022-02-09

Review 2.  An Updated Review of Recent Advances in Neurosyphilis.

Authors:  Jia Zhou; Hanlin Zhang; Keyun Tang; Runzhu Liu; Jun Li
Journal:  Front Med (Lausanne)       Date:  2022-09-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.